State Street’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.2M | Sell |
4,173,763
-208,411
| -5% | -$709K | ﹤0.01% | 2378 |
|
|
2025
Q1 | $17.6M | Sell |
4,382,174
-128,204
| -3% | -$514K | ﹤0.01% | 2208 |
|
|
2024
Q4 | $29.3M | Buy |
4,510,378
+342,877
| +8% | +$2.23M | ﹤0.01% | 2001 |
|
|
2024
Q3 | $23.1M | Buy |
4,167,501
+194,369
| +5% | +$1.08M | ﹤0.01% | 2124 |
|
|
2024
Q2 | $22.2M | Sell |
3,973,132
-142,727
| -3% | -$796K | ﹤0.01% | 2121 |
|
|
2024
Q1 | $27.6M | Buy |
4,115,859
+118,090
| +3% | +$792K | ﹤0.01% | 2034 |
|
|
2023
Q4 | $36.5M | Buy |
3,997,769
+220,226
| +6% | +$2.01M | ﹤0.01% | 1873 |
|
|
2023
Q3 | $20.9M | Buy |
3,777,543
+370,108
| +11% | +$2.04M | ﹤0.01% | 2156 |
|
|
2023
Q2 | $29.1M | Buy |
3,407,435
+1,348,163
| +65% | +$11.5M | ﹤0.01% | 1999 |
|
|
2023
Q1 | $18.9M | Buy |
2,059,272
+20,927
| +1% | +$192K | ﹤0.01% | 2265 |
|
|
2022
Q4 | $20.8M | Buy |
2,038,345
+8,092
| +0.4% | +$82.6K | ﹤0.01% | 2218 |
|
|
2022
Q3 | $29.9M | Buy |
2,030,253
+304,433
| +18% | +$4.48M | ﹤0.01% | 1943 |
|
|
2022
Q2 | $18.5M | Buy |
1,725,820
+405,162
| +31% | +$4.35M | ﹤0.01% | 2307 |
|
|
2022
Q1 | $14.2M | Buy |
1,320,658
+1,048,629
| +385% | +$11.3M | ﹤0.01% | 2627 |
|
|
2021
Q4 | $4.44M | Buy |
272,029
+64,590
| +31% | +$1.05M | ﹤0.01% | 3297 |
|
|
2021
Q3 | $4.44M | Buy |
+207,439
| New | +$4.44M | ﹤0.01% | 3303 |
|